That was weird, page-14

Cheers Martin- I understood them to be collecting trial data in 'buckets' relevant to individual disease types and submitting as these trial samples became of required size/statistical validity. Based on the anticipated rapid uptake across multiple busy hospitals, concurrent disease trialling could occur in rapid succession.

Happy to be corrected though as pneumonia + asthma submission together would be faster/bigger market share initially.